Loading Events

Event

 

Speakers will address the highest-priority elements of the nation’s response to the opioid epidemic particularly in the context of COVID-19.

 

The National Academy of Medicine (NAM), established the Action Collaborative on Countering the U.S. Opioid Epidemic in 2018 as a two-year, public-private partnership to foster greater coordination and collective action across the health system and beyond in addressing the opioid addiction crisis. The Action Collaborative uses a systems approach to convene and catalyze public, private, and non-profit stakeholders to develop, curate, and disseminate multi-sector solutions designed to reduce opioid misuse, and improve outcomes for individuals, families, and communities affected by the opioid crisis.

During this virtual symposium, Action Collaborative members and invited expert speakers will address among the highest-priority elements of the nation’s response to the opioid epidemic, particularly in the context of the COVID-19 pandemic. Over the course of the day, participants will learn about the most promising opportunities to achieve a health system that is better prepared to prevent, treat, and manage substance use disorders.

 

Virtual Symposium Agenda

8:30 to 9 a.m. | Welcome & Opening Remarks

Welcome and meeting overview

  • Elizabeth Finkelman, Director, Action Collaborative on Countering the U.S. Opioid Epidemic, National Academy of Medicine

Opening remarks from the Action Collaborative co-chairs

  • Victor Dzau, President, National Academy of Medicine
  • Ruth Katz, Director of the Health, Medicine and Society Program, The Aspen Institute
  • Jonathan Perlin, President, Clinical Services and Chief Medical Officer, HCA Healthcare 
  • ADM Brett Giroir, Assistant Secretary for Health, U.S. Department of Health and Human Services

9 to 9:20 a.m. | The Effects of Stigma: Perspectives from Persons with Lived Experience

  • Marcie A. Massa, Shatterproof Ambassador
  • Maegan M. Kenney, M.A., Shatterproof Ambassador

9:20 to 10:30 a.m. | Session 1: Addressing the Stigma Surrounding Opioid Use Disorder
Moderator: Kelly Clark, Immediate Past President, American Society of Addiction Medicine

  • Matthew Stefanko, Director, National Stigma Initiative, Shatterproof
  • Margaret A. Jarvis, Chief of Addiction Services for Geisinger Addiction Medicine and the Geisinger Neuroscience Institute 
  • Colleen L. Barry, Chair, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health 
  • Joy Rucker, Executive Director, Texas Harm Reduction Alliance

10:30 to 10:50 a.m. | Break

10:50 a.m. to 12 p.m. | Session 2: Health Professional Education & Training: Persisting Gaps and Promising Practices
Moderator: Steve Singer, Vice President of Education and Outreach, Accreditation Council for Continuing Medical Education

  • Richard Bottner, PA-C, Affiliate Faculty, Department of Internal Medicine, Dell Medical School at the University of Texas Austin 
  • Daniel Alford,Professor of Medicine, Associate Dean, CME and Director, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine, Boston Medical Center
  • Charlene M. Dewey, Professor, Department of Medicine, Division of Internal Medicine, Director, Center for Professional Health and the Prescribing Controlled Drugs (PCD) Course, Professor of Medical Education and Administration, Vanderbilt University Medical Center/Vanderbilt University School of Medicine
  • Deborah Finnell, Professor Emerita, The Johns Hopkins University School of Nursing

12 to 12:40 p.m. | Break

12:40 to 1:50 p.m. | Session 3: Person-Centered, Evidence-based Pain Management 
Moderator: Helen Burstin, CEO, Council of Medical Specialty Societies

  • Roger Chou, Professor in the Departments of Medicine, and Medical Informatics & Clinical Epidemiology at Oregon Health & Science University
  • Robert (“Chuck) Rich, Jr., Medical Director, Community Care of the Lower Cape Fear, Wilmington, NC
  • Christina Mikosz, Medical Officer, Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention
  • Daniel Knecht, Vice President, Health Strategy and Innovation, CVS Health
  • Penney Cowan, Founder and CEO, American Chronic Pain Association 

1:50 to 2:10 p.m. | Break

2:10 to 3:20 p.m. | Session 4: Moving Away from a Treatment Only Approach: Accelerating Evidence-based OUD Prevention Practices
Moderator: Alonzo Plough, Chief Science Officer, Robert Wood Johnson Foundation

  • Elizabeth Salisbury-Afshar, Director, Center for Addiction Research and Effective Solutions, American Institutes for Research 
  • Helena Hansen, Associate Professor, Department of Psychiatry, NYU 
  • Marcus Plescia, Chief Medical Officer, Association of State and Territorial Health Officials
  • Devin Reaves, Executive Director, Pennsylvania Harm Reduction Coalition 

3:20 to 3:40 p.m. | Break

3:40 to 4:50 p.m. | Session 5: Building a Health System that is Equipped to Prevent, Treat, and Manage OUD
Moderator: Andrey Ostrovsky, Managing Partner, Social Innovation Ventures

  • Corey Waller, Principal, Health Management Associates
  • Kelly Clark, Immediate Past President, ASAM 
  • Kate Berry, Senior Vice President of Clinical Affairs and Strategic Partnerships, America’s Health Insurance Plans
  • Shari Ling, Acting Chief Medical Officer, CMS
  • Sherry Dubester, Executive Vice President and Chief Medical Officer, Beacon Health Options

4:50 to 5 p.m. | Closing Remarks

5 p.m. | Adjourn Public Session

Join Our Community

Sign up for NAM email updates